Anthony Loumidis

Anthony Loumidis has a diverse work experience spanning over several companies and industries. Anthony most recently served as the Chief Financial Officer at Innovive Health, a healthcare company focused on patient-centered, data-driven, full-service home care. Before that, they held the same position at VERO Biotech from 2013 to 2017. Prior to their time at VERO, they served as the Chief Financial Officer at EuroSite Power Limited from 2010 to 2013. From 2004 to 2013, Anthony served as the Chief Financial Officer at American DG Energy. Anthony also held the position of Chief Financial Officer at GlenRose Instruments from 2005 to 2013, where they oversaw radiological services and operated an analytical laboratory network. Earlier in their career, Anthony served as the Vice President & Treasurer at Tecogen Inc. from 2007 to 2012 and as the President of Alexandros Partners LLC from 2000 to 2011. Anthony started their career at Thermo Fisher Scientific, where they held various roles including National Sales Manager, Financial Services, Manager, Investor Relations, and Manager, Business Development from 1989 to 2000. Anthony also has experience serving in the Hellenic Army as a Reserve Second Lieutenant from 1986 to 1988.

Anthony Loumidis has a diverse education history. Anthony attended the Harvard Business School Executive Education from 2019 to 2022, where they pursued a degree in Managing Health Care Delivery. Prior to that, they obtained their MBA from the D'Amore-McKim School of Business at Northeastern University between 1989 and 1993, specializing in Finance. Their undergraduate studies took place at The American College of Greece from 1982 to 1988, where they earned a Bachelor of Science in Business Administration with a focus on Marketing.

In addition to their formal education, Loumidis also holds the certification of Series 7 Registered Representative, obtained from FINRA in September 2004.